ANVISA-2020-0005-V205

Type II variation for application ANVISA-2020-0005. Type II variation: Labeling Change for Tisagenlecleux-B — major revision

Variation Number
ANVISA-2020-0005-V205
Type
Type II
Application
ANVISA-2020-0005
Change
CHG-2024-0205
Status
Approved
Fee
€19,698
Submitted
2023-01-13
Approved
2024-01-31
Description

Type II variation: Labeling Change for Tisagenlecleux-B — major revision